Vacuna anticovid UNAM no puede avanzar más rápido por infraestructura
El proyecto se encuentra en validar las pruebas preclínicas que demostraron que la vacuna es segura y produce inmunidad.
Source: milenio.com
📰 Edda Sciutto News
Edda Sciutto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edda Sciutto. Real-time updates on events, politics, business and more.
This is how the creation of vaccines against COVID-19 in Latin America progresses
more than 300 candidates for vaccines against COVID-19 that had been registered all over the planet. Of these, at least twelve had already passed the third clinical phase, for which their use in humans had been approved. As expected, European countries, China and the United States were the ones that took advantage in the race to obtain a vaccine. Biologics such as those from Pfizer (United States), Sinovac (China), AstraZeneca (United Kingdom) and Sputnik V (Russia), have been the most popular ...
Source: latinamericanpost.com